Serum nitrite and nitrate levels in epileptic children using valproic acid or carbamazepine

Brain and Development

Volumn 26, Issue 1, 2004, Pages 15-18

  Karabiber, Hamza ^a   Yakinci, Cengiz ^b   Durmaz, Yasar ^c   Temel, Ismail ^b   Mehmet, Nihayet ^b  

^a KSU Medical School   (Turkey)

^b INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Department of Pediatrics   (Turkey)

Author keywords

Carbamazepine; Epileptic children; Nitric oxide; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; NITRATE; NITRITE; VALPROIC ACID;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; BLOOD LEVEL; CHILD; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; STATISTICAL ANALYSIS;

EID: 0346461490     PISSN: 03877604     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0387-7604(03)00076-7     Document Type: Article

References (25)

1. Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric oxide: a physiologic messenger. Ann Intern Med. 120:1994;227-237.
2. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 43:1991;109-142.
3. Kimura S., Watanabe K., Yajiri Y., Motegi T., Masuya Y., Shibuki K., et al. Cerebrospinal fluid nitric oxide metabolites in painful diseases. Neuroreport. 10:1999;275-279.
4. Ikeda M., Sato I., Yuasa T., Miyatake T., Murota S. Nitrite, nitrate and cGMP in the cerebrospinal fluid in degenerative neurologic diseases. J Neural Transm Gen Sect. 100:1995;263-267.
5. Navarro J.A., Molina J.A., Jimenez-Jimenez F.J., Benito-Leon J., Orti-Pareja M., Gasalla T., et al. Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease. Acta Neurol Scand. 94:1996;411-414.
6. Zecca L., Rosati M., Renella R., Galimberti M., Ambrosini A., Fariello R.G. Nitrite and nitrate levels in cerebrospinal fluid normal subjects. J Neural Transm. 105:1998;627-633.
7. Kuiper M.A., Visser J.J., Bergmans P.L., Scheltens P., Wolters E.C. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease. Alzheimer's disease and multiple system atrophy patients. J Neurol Sci. 121:1994;46-49.
8. Lipton S.A., Choi Y.B., Pan Z.H., Lei S.Z., Chen H.S., Sucher N.J., et al. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
9. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull. 41:1996;131-141.
10. Kirkby D.R., Carroll D.M., Grossman A.B., Subramaniam S. Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res. 24:1996;91-100.
11. Cortas N.K., Wakid N.W. Determination of inorganic nitrate in serum and urine by kinetic cadmium-reduction method. Clin Chem. 36:1990;1440-1443.
12. 15N(nitrate in biological fluids. Anal Biochem. 126:1982;131-138.
13. Bashkatova V.G., Rayevsky K.S. Nitric oxide in mechanisms of brain damage induced by neurotoxic effect of glutamate. Biochemistry (Mosc). 63:1998;866-873.
14. Smith S.E., Man C.M., Yip P.K., Tang E., Chapman A.G., Meldrum B.S. Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol. 119:1996;165-173.
15. Rundfeldt C., Koch R., Richter A., Mevissen M., Gerecke U., Loscher W. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats. Eur J Pharmacol. 274:1995;73-81.
16. Sandirasegarane L., Mikler J.R., Tuchek J.M., Sulakhe P.V. Enhanced forebrain nitric oxide synthase activity in epileptic fowl. Brain Res. 735:1996;311-313.
17. Boda B., Szente M. Nitric oxide synthase inhibitor facilitates focal seizures induced by aminopyridine in rat. Neurosci Lett. 209:1996;37-40.
18. Yokoi I., Kabuto H., Habu H., Mori A. alpha-Guanidinoglutaric acid, an endogenous convulsant, as a novel nitric oxide synthase inhibitor. J Neurochem. 63:1994;1565-1567.
19. Kabuto H., Yokoi I., Habu H., Willmore L.J., Mori A., Ogawa N. Reduction in nitric oxide synthase activity with development of an epileptogenic focus induced by ferric chloride in rat brain. Epilepsy Res. 25:1996;65-68.
20. Nagatomo I., Akasaki Y., Uchida M., Tominaga M., Hashiguchi W., Takigawa M. Effects of combined administration of zonisamide and valproic acid or phenytoin to nitric oxide production, monoamines and zonisamide concentrations in the brain of seizure-susceptible EL mice. Brain Res Bull. 53:2000;211-218.
21. Tominaga M., Nagatomo I., Uchida M., Hashiguchi W., Akasaki Y., Takigawa M. Alterations of nitric oxide and monoamines in the brain of the EL mouse treated with phenobarbital and zonisamide. Psychiatry Clin Neurosci. 55:2001;311-318.
22. Uchida M., Nagatomo I., Akasaki Y., Tominaga M., Hashiguchi W., Kuchiiwa S., et al. Nitric oxide production is decreased in the brain of the seizure susceptible EL mouse. Brain Res Bull. 50:1999;223-227.
23. Suzuki E., Nakaki T., Shintani F., Kanba S., Miyaoka H. Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain. Neurosci Lett. 333:2002;217-219.
24. Faradji H., Rousset C., Debilly G., Vergnes M., Cespuglio R. Sleep and epilepsy: A key role for nitric oxide? Epilepsia. 41:2000;794-801.
25. Thompson C.M., Bernhard A.E., Strobel H.W. Barbiturate-induced expression of neuronal nitric oxide synthase in the rat cerebellum. Brain Res. 754:1997;142-146.